DS
AQST icon

David Shaw’s Aquestive Therapeutics AQST Stock Holding History

David Shaw’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
37,640
+19,491
+107% +$82K ﹤0.01% 4585
2026
Q1 		$75.3K Sell
18,149
-923,048
-98% -$3.75M ﹤0.01% 4312
2025
Q4 		$6.08M Buy
941,197
+915,697
+3,591% +$5.71M ﹤0.01% 2146
2025
Q3 		$143K Sell
25,500
-39,176
-61% -$169K ﹤0.01% 4322
2025
Q2 		$214K Sell
64,676
-114,359
-64% -$328K ﹤0.01% 4034
2025
Q1 		$519K Buy
179,035
+52,571
+42% +$159K ﹤0.01% 3487
2024
Q4 		$450K Buy
126,464
+95,418
+307% +$440K ﹤0.01% 3680
2024
Q3 		$155K Buy
31,046
+20,858
+205% +$81.2K ﹤0.01% 4206
2024
Q2 		$26.5K Sell
10,188
-85,025
-89% -$284K ﹤0.01% 4256
2024
Q1 		$406K Buy
+95,213
New +$317K ﹤0.01% 3589
2022
Q3 		– Sell
-164,607
Closed -$106K – 5167
2022
Q2 		$106K Buy
164,607
+55,769
+51% +$74.2K ﹤0.01% 4714
2022
Q1 		$284K Buy
108,838
+21,052
+24% +$61.5K ﹤0.01% 4679
2021
Q4 		$341K Buy
+87,786
New +$441K ﹤0.01% 4618
2020
Q3 		– Sell
-283,418
Closed -$1.38M – 3807
2020
Q2 		$1.38M Buy
283,418
+69,196
+32% +$319K ﹤0.01% 2697
2020
Q1 		$469K Sell
214,222
-49,195
-19% -$187K ﹤0.01% 3241
2019
Q4 		$1.53M Buy
+263,417
New +$1.37M ﹤0.01% 2684

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

David Shaw's AQST Position: Q2 2026 in Review

David Shaw increased its Aquestive Therapeutics (AQST) stake by 107% in Q2 2026, buying an estimated $82K and bringing the position to 37,640 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #4585.

David Shaw first reported a position in AQST in Q4 2019 and has held it in 16 quarters since. The position peaked at $6.08M in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • David Shaw held 37,640 shares of Aquestive Therapeutics worth $157K as of Q2 2026.
  • David Shaw bought 19,491 Aquestive Therapeutics shares in Q2 2026, an estimated $82K.
  • Aquestive Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4585 holding.
  • David Shaw first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 16 quarters since.
  • David Shaw's Aquestive Therapeutics position peaked at $6.08M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.